Real-world outcomes in 2,646 psoriasis patients : one in five has PASI ≥ 10 and/or DLQI ≥ 10 under ongoing systemic therapy

MLA

Norlin, J. M., et al. Real-World Outcomes in 2,646 Psoriasis Patients : One in Five Has PASI ≥ 10 and/or DLQI ≥ 10 under Ongoing Systemic Therapy. 2017. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1234524052&authtype=sso&custid=ns315887.

APA

Norlin, J. M., Calara, P. S., Persson, U., & Schmitt-Egenolf, M. (2017). Real-world outcomes in 2,646 psoriasis patients : one in five has PASI ≥ 10 and/or DLQI ≥ 10 under ongoing systemic therapy.

Chicago

Norlin, J. M., P. S. Calara, U. Persson, and Marcus Schmitt-Egenolf. 2017. “Real-World Outcomes in 2,646 Psoriasis Patients : One in Five Has PASI ≥ 10 and/or DLQI ≥ 10 under Ongoing Systemic Therapy.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1234524052&authtype=sso&custid=ns315887.